DistilINFO
Recent Posts
HomeHealth AiWhat Builds Physician Trust in Clinical AI

What Builds Physician Trust in Clinical AI

Physician

Physician use of AI has roughly doubled in three years, but the conditions clinicians set for trust in clinical AI have barely shifted: show the evidence, protect the data, and make clear who is accountable. Some 81 percent of physicians reported using AI in their practices in 2026, up from 38 percent in 2023, according to the American Medical Association’s annual survey on augmented intelligence.

Adoption at that pace raises a practical question for health systems: what has to be true before a clinician relies on an AI output in a patient encounter? Survey data and accreditation guidance point to answers across clinical, operational, patient and organizational dimensions.

What Physicians Say Builds Trust in Clinical AI

The AMA’s 2026 survey found adoption rising alongside persistent conditions. Physicians averaged 2.3 AI use cases, up from 1.1 in 2023, with research summarization and clinical documentation most common. More than three-quarters said AI improves their ability to care for patients, up from 65 percent in 2023.

The conditions attached to that trust are specific:

  • 88 percent called robust safety and efficacy validation critical
  • 86 percent cited data privacy assurances
  • Clear liability frameworks ranked highest among regulatory actions physicians consider essential
  • 85 percent want to be consulted or directly involved in AI adoption decisions

Concerns have not disappeared with familiarity. Forty percent described themselves as equally excited and concerned, citing patient privacy and the integrity of the patient-physician relationship. Notably, 88 percent worried about skill loss, a concern concentrated among physicians with 10 or fewer years in practice.

“It is critical that augmented intelligence be designed to enhance, not replace, physicians,” AMA CEO John Whyte, MD, said in announcing the results.

Where Patients Draw Lines

Physicians distinguish sharply between AI uses by patients. The AMA found they generally support patients using AI for general health and medication questions, but most oppose patient use for tasks requiring clinical judgment, with nearly half strongly opposed to patients using AI to interpret radiology or pathology results.

That distinction is becoming harder to maintain in practice. A JAMA study published Oct. 15 found about 952,000 U.S. clinicians submitted roughly 271 million queries to a single AI clinical information platform over two and a half years, with monthly users rising from 355 to more than 703,000. Patients, meanwhile, are connecting their own records to consumer chatbots.

What Accreditors Expect

The Joint Commission and the Coalition for Health AI issued joint guidance in September 2025 setting out seven components of responsible AI use:

  • AI policies and governance structures, including cross-functional teams and regular board updates
  • Patient privacy and transparency, with disclosure and consent options where appropriate
  • Data security protections, including deidentification of training data and incident response plans
  • Ongoing quality monitoring, with regular validation of AI outputs over time
  • Voluntary, blinded reporting of AI safety events, handled like other adverse events
  • Risk and bias assessment conducted with developers and vendors
  • Education and training, both use-case-specific and general AI literacy

The guidance is advisory, but the organizations said they would follow it with governance playbooks and a voluntary AI certification for the Joint Commission’s roughly 22,000 accredited organizations. “The need is immediate, and we are eager to respond,” CHAI CEO Brian Anderson, MD, said at the time.

Trust in Clinical AI Hinges on Accountability

The hardest dimension is the one physicians rank highest and that no survey can resolve. If an AI tool contributes to a poor outcome, responsibility may rest with the clinician who acted on it, the health system that deployed it, or the vendor that built it, and current law does not settle the question.

That gap explains why physicians put liability frameworks above other regulatory priorities, and why organizational governance matters beyond compliance paperwork. A health system that cannot document which tools are in use, what they were validated for and who reviewed them has no defensible position if something goes wrong.

What It Means for Health Systems

Trust in clinical AI is being built or lost at the implementation level rather than in vendor claims. The practical steps that follow from the evidence are unremarkable: validate tools for the specific use case rather than the vendor’s general claims, require source citations in clinical outputs, monitor performance after deployment rather than only at purchase, and involve clinicians in selection decisions, which the overwhelming majority expect.

The alternative is the pattern already visible in the usage data: clinicians adopting tools on their own, outside any governance framework, while institutions write policies for deployments they control.

For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.

Written by

The DistilINFO Editorial Team covers healthcare payer, provider, government health, life sciences and health AI news for more than 135,000 industry decision makers. Since 2016, DistilINFO has published daily briefings that summarize the developments that matter most to health plans, health systems and the organizations that serve them. Our stories are based on primary sources, including press releases, regulatory filings, CMS and HHS announcements, and peer-reviewed research, which we cite and link in every article. Questions or corrections: digital@distilinfo.com.

No comments

Sorry, the comment form is closed at this time.